Paragon Capital Management (Utah)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
MBI
CGI
WJWM
Paragon Capital Management (Utah)'s IDXX Position: Q2 2026 in Review
Paragon Capital Management (Utah) reduced its Idexx Laboratories (IDXX) stake by 1.3% in Q2 2026, selling an estimated $16.3K and leaving 2,286 shares worth $1.2M. The position accounts for 0.89% of the portfolio, ranked #39.
Paragon Capital Management (Utah) first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.22M in Q3 2025. 659 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Paragon Capital Management (Utah) held 2,286 shares of Idexx Laboratories worth $1.2M as of Q2 2026.
- Paragon Capital Management (Utah) sold 29 Idexx Laboratories shares in Q2 2026, an estimated $16.3K.
- Idexx Laboratories made up 0.89% of Paragon Capital Management (Utah)'s portfolio in Q2 2026, its #39 holding.
- Paragon Capital Management (Utah) first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
- Paragon Capital Management (Utah)'s Idexx Laboratories position peaked at $2.22M in Q3 2025.
- 659 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Paragon Capital Management (Utah)'s 13F filing for Q2 2026, filed 22 Jul 2026.